🇺🇸 FDA
Patent

US 12270814

Kits and methods for prediction and treatment of preeclampsia

granted A61KA61K35/16

Quick answer

US patent 12270814 (Kits and methods for prediction and treatment of preeclampsia) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/16